Holdings of BNP Paribas Funds Health Care Innovators
BNP Paribas Asset Management Luxembourg · 49 declared positions · as of Dec 31, 2025
Fund report · Ten largest lines: 51.1 % of net assets · Compare with another fund · Report an error
Positions
| Rank | Company | Currency | Shares | Value | Weight |
|---|---|---|---|---|---|
| 1 | ELI LILLY & CO Etats-Unis d'Amérique | USD | 189,850 | 173.7M € | 9.69 % |
| 2 | ASTRAZENECA PLC Royaume-Uni | GBP | 862,701 | 136.2M € | 7.61 % |
| 3 | BOSTON SCIENTIFIC Etats-Unis d'Amérique | USD | 1,108,028 | 90M € | 5.01 % |
| 4 | VERTEX PHARMACEUTICALS INCORPORATED Etats-Unis d'Amérique | USD | 227,741 | 87.9M € | 4.90 % |
| 5 | SANOFI France | EUR | 981,787 | 81.2M € | 4.53 % |
| 6 | INTUITIVE SURGICAL INCORPORATED Etats-Unis d'Amérique | USD | 167,219 | 80.6M € | 4.50 % |
| 7 | THERMO FISHER SCIENTIFIC INC Etats-Unis d'Amérique | USD | 141,507 | 69.8M € | 3.89 % |
| 8 | JAZZ PHARMACEUTICALS PLC Irlande | USD | 473,157 | 68.5M € | 3.82 % |
| 9 | GILEAD SCIENCES Etats-Unis d'Amérique | USD | 647,274 | 67.6M € | 3.77 % |
| 10 | UCB SA Belgique | EUR | 256,049 | 61.1M € | 3.41 % |
| 11 | NEUROCRINE BIOSCIENCES INC Etats-Unis d'Amérique | USD | 490,816 | 59.3M € | 3.30 % |
| 12 | ABBVIE INCORPORATED Etats-Unis d'Amérique | USD | 242,630 | 47.2M € | 2.63 % |
| 13 | IONIS PHARMACEUTICALS INC Etats-Unis d'Amérique | USD | 652,857 | 44M € | 2.45 % |
| 14 | DAIICHI SANKYO CO LTD Japon | JPY | 2,302,200 | 41.9M € | 2.34 % |
| 15 | EDWARDS LIFESCIENCES CORPORATION Etats-Unis d'Amérique | USD | 570,420 | 41.4M € | 2.31 % |
| 16 | LONZA GROUP AG - REG Suisse | CHF | 64,267 | 37.1M € | 2.07 % |
| 17 | ALCON INC Suisse | CHF | 509,849 | 34.7M € | 1.93 % |
| 18 | UNITEDHEALTH GROUP INCORPORATED Etats-Unis d'Amérique | USD | 120,719 | 33.9M € | 1.89 % |
| 19 | ARGENX SE - ADR Pays-Bas | USD | 47,163 | 33.8M € | 1.88 % |
| 20 | CRINETICS PHARMACEUTICALS IN Etats-Unis d'Amérique | USD | 808,494 | 32M € | 1.79 % |
| 21 | IRHYTHM TECHNOLOGIES INC Etats-Unis d'Amérique | USD | 199,686 | 30.2M € | 1.68 % |
| 22 | ALPHATEC HOLDINGS INC Etats-Unis d'Amérique | USD | 1,601,737 | 28.7M € | 1.60 % |
| 23 | REPLIGEN CORP Etats-Unis d'Amérique | USD | 190,462 | 26.6M € | 1.48 % |
| 24 | MASIMO CORP Etats-Unis d'Amérique | USD | 231,951 | 25.7M € | 1.43 % |
| 25 | PROCEPT BIOROBOTICS CORP Etats-Unis d'Amérique | USD | 958,619 | 25.7M € | 1.43 % |
| 26 | CYTOKINETICS INC Etats-Unis d'Amérique | USD | 439,474 | 23.8M € | 1.33 % |
| 27 | VERICEL CORP Etats-Unis d'Amérique | USD | 751,500 | 23M € | 1.28 % |
| 28 | GENMAB A/S Danemark | DKK | 83,902 | 22.8M € | 1.27 % |
| 29 | PENUMBRA INC Etats-Unis d'Amérique | USD | 80,057 | 21.2M € | 1.18 % |
| 30 | INSMED INC Etats-Unis d'Amérique | USD | 124,952 | 18.5M € | 1.03 % |
| 31 | REGENERON PHARMACEUTICALS Etats-Unis d'Amérique | USD | 27,943 | 18.4M € | 1.02 % |
| 32 | PTC THERAPEUTICS INC Etats-Unis d'Amérique | USD | 237,427 | 15.4M € | 0.86 % |
| 33 | NEWAMSTERDAM PHARMA CO NV Pays-Bas | USD | 513,917 | 15.4M € | 0.86 % |
| 34 | ATRICURE INC Etats-Unis d'Amérique | USD | 410,426 | 13.8M € | 0.77 % |
| 35 | SCHOLAR ROCK HOLDING CORP Etats-Unis d'Amérique | USD | 355,268 | 13.3M € | 0.74 % |
| 36 | XENON PHARMACEUTICALS INC Canada | USD | 344,209 | 13.1M € | 0.73 % |
| 37 | ADAPTIVE BIOTECHNOLOGIES Etats-Unis d'Amérique | USD | 931,155 | 12.9M € | 0.72 % |
| 38 | AGIOS PHARMACEUTICALS INC Etats-Unis d'Amérique | USD | 536,237 | 12.4M € | 0.69 % |
| 39 | IDEAYA BIOSCIENCES INC Etats-Unis d'Amérique | USD | 407,671 | 12M € | 0.67 % |
| 40 | PROTAGONIST THERAPEUTICS INC Etats-Unis d'Amérique | USD | 154,566 | 11.5M € | 0.64 % |
| 41 | ASCENDIS PHARMA A/S - ADR Danemark | USD | 60,710 | 11M € | 0.61 % |
| 42 | ZYMEWORKS INC Etats-Unis d'Amérique | USD | 488,557 | 11M € | 0.61 % |
| 43 | ARCUS BIOSCIENCES INC Etats-Unis d'Amérique | USD | 515,593 | 10.5M € | 0.58 % |
| 44 | ULTRAGENYX PHARMACEUTICAL IN Etats-Unis d'Amérique | USD | 532,514 | 10.4M € | 0.58 % |
| 45 | SYNDAX PHARMACEUTICALS INC Etats-Unis d'Amérique | USD | 546,923 | 9.8M € | 0.55 % |
| 46 | WAVE LIFE SCIENCES LTD Singapour | USD | 569,581 | 8.2M € | 0.46 % |
| 47 | NUVALENT INC-A Etats-Unis d'Amérique | USD | 60,702 | 5.2M € | 0.29 % |
| 48 | BICYCLE THERAPEUTICS PLC-ADR Royaume-Uni | USD | 568,225 | 3.4M € | 0.19 % |
| 49 | UNIQURE NV Pays-Bas | USD | 114,811 | 2.3M € | 0.13 % |
Source: report published by BNP Paribas Funds Health Care Innovators.
Country breakdown
- Etats-Unis d'Amérique 67.9 %
- Royaume-Uni 7.9 %
- France 4.6 %
- Suisse 4.0 %
- Irlande 3.9 %
- Belgique 3.4 %
- Pays-Bas 2.9 %
- Japon 2.4 %
- Danemark 1.9 %
- Canada 0.7 %
- Singapour 0.5 %
The countries are those of the fund report. Weights are in % of net assets.
Currency breakdown
- USD 76.7 %
- EUR 8.0 %
- GBP 7.7 %
- CHF 4.0 %
- JPY 2.4 %
- DKK 1.3 %
Each line is counted in its quoted currency, as the fund declares it.
Cite this page
Titelia. "Holdings of BNP Paribas Funds Health Care Innovators". https://titelia.com/en/funds/bnp-paribas-funds-health-care-innovators